ASLNASLAN Pharmaceuticals Ltd

Nasdaq www.aslanpharma.com


$ 0.61 $ -0.09 (-12.84 %)    

Thursday, 18-Jul-2024 13:41:13 EDT
QQQ $ 478.10 $ -7.40 (-1.52 %)
DIA $ 407.27 $ -3.86 (-0.94 %)
SPY $ 552.21 $ -6.13 (-1.1 %)
TLT $ 93.74 $ 0.07 (0.08 %)
GLD $ 226.60 $ -1.10 (-0.49 %)
$ 0.6999
$ 0.75
$ 0.00 x 0
$ 0.00 x 0
$ 0.60 - $ 0.75
$ 0.48 - $ 25.44
2,820,324
na
10.68M
$ 1.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-aslan-pharmaceuticals-asln-shares-are-down-40

ASLAN Pharmaceuticals shares are trading lower by 40.6% during Wednesday's session. The company announced that its Singapor...

 aslan-pharmaceuticals-announces-receipt-of-nasdaq-delisting-determination-for-non-compliance-of-bid-price-and-stockholders-qquity-requirements

ASLAN Pharmaceuticals (("ASLAN" or the "Company", NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmac...

 aslan-pharmaceuticals-announces-plan-to-implement-ads-ratio-change-from-1-ads-representing-25-shares-to-1-ads-representing-200-shares-1-for-8-ads-split-effective-date-for-the-ratio-change-july-3-2024

ASLAN Pharmaceuticals (("ASLAN" or the "Company", NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmac...